SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-211058
Filing Date
2017-06-23
Accepted
2017-06-23 08:01:36
Documents
6
Period of Report
2017-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d418192d8k.htm 8-K 30358
2 EX-2.1 d418192dex21.htm EX-2.1 990447
3 EX-10.1 d418192dex101.htm EX-10.1 52909
4 EX-99.1 d418192dex991.htm EX-99.1 25521
5 GRAPHIC g418192g0623022729185.jpg GRAPHIC 4695
6 GRAPHIC g418192g91c74.jpg GRAPHIC 282602
  Complete submission text file 0001193125-17-211058.txt   1496441
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 17926361
SIC: 2836 Biological Products, (No Diagnostic Substances)